| Arena Pharmaceuticals, Inc. | (NQ: ARNA) |
|
USD
|
|
Streaming Delayed Price
/ Updated: /
|
| View: | Quote | News | Research |
(ARNA) Community Analysis from
Bulls REASONS TO BUY
|
89%
agree
29 votes
|
Obesity Drug Could Have Huge Impact on World Health |
Bears REASONS TO SELL
June 19, 2013
(Stock Blog Hub,
10/23/12)
Arena Pharmaceuticals, Inc. (ARNA) recently initiated a phase I multiple dose study with APD811, which is being developed for the treatment of pulmonary arterial hypertension...(read more)
(Investment Underground » Page n...,
4/19/12)
by Kelly Jamrozy
The weight loss industry is a booming business, but one of the places it often struggles is with prescription weight loss drugs. This is...(read more)
(Phil’s Stock World,
2/23/12)
Courtesy of Benzinga. Americans have gotten so irreversibly out of shape that the markets think we are going to need a [...]
Arena Pharmaceuticals (ARNA) Company Overview
There is no analysis for ARNA yet. But you can go to Wikinvest to help create one!
